Suppr超能文献

在肯尼亚西部,接受一线抗逆转录病毒疗法治疗失败的母婴传播感染的儿童和青少年中,HIV-1 治疗失败、耐药性和临床结局。

HIV-1 Treatment Failure, Drug Resistance, and Clinical Outcomes in Perinatally Infected Children and Adolescents Failing First-Line Antiretroviral Therapy in Western Kenya.

机构信息

Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.

Moi University College of Health Sciences, Eldoret, Kenya.

出版信息

J Acquir Immune Defic Syndr. 2022 Feb 1;89(2):231-239. doi: 10.1097/QAI.0000000000002850.

Abstract

BACKGROUND

Long-term impact of drug resistance in perinatally infected children and adolescents living with HIV (CALWH) is poorly understood. We determined drug resistance and examined its long-term impact on failure and mortality in Kenyan CALWH failing first-line non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy (ART).

SETTING

Academic Model Providing Access to Healthcare, western Kenya.

METHODS

Participants were enrolled in 2010-2013 (timepoint 1) and a subsample re-enrolled after 4-7 years (timepoint 2). Viral load (VL) was performed on timepoint 1 samples, with genotyping of those with detectable VL. Primary endpoints were treatment failure (VL >1000 copies/mL) at and death before timepoint 2. Multinomial regression analysis was used to characterize resistance effect on death, failure, and loss-to-follow-up, adjusting for key variables.

RESULTS

The initial cohort (n = 480) was 52% (n = 251) female, median age 8 years, median CD4% 31%, 79% (n = 379) on zidovudine/abacavir + lamivudine + efavirenz/nevirapine for median 2 years. Of these, 31% (n = 149) failed at timepoint 1. Genotypes at timepoint 1, available on n = 128, demonstrated 93% (n = 119) extensive resistance, affecting second line. Of 128, 22 failed at timepoint 2, 17 died, and 32 were lost to follow-up before timepoint 2. Having >5 resistance mutations at timepoint 1 was associated with higher mortality [relative risk ratio (RRR) = 8.7, confidence interval (CI) 2.1 to 36.3] and loss to follow-up (RRR = 3.2, CI 1.1 to 9.2). Switching to second line was associated with lower mortality (RRR <0.05, CI <0.05 to 0.1) and loss to follow-up (RRR = 0.1, CI <0.05 to 0.3).

CONCLUSION

Extensive resistance and limited switch to second line in perinatally infected Kenyan CALWH failing first-line ART were associated with long-term failure and mortality. Findings emphasize urgency for interventions to sustain effective, life-long ART in this vulnerable population.

摘要

背景

围生期感染艾滋病毒的儿童和青少年(CALWH)中药物耐药的长期影响尚未完全清楚。我们确定了耐药性,并研究了其对肯尼亚首例一线非核苷类逆转录酶抑制剂为基础的抗逆转录病毒治疗(ART)失败的 CALWH 患者发生失败和死亡的长期影响。

地点

肯尼亚西部学术医疗模式提供的医疗保健。

方法

参与者于 2010-2013 年入组(时间点 1),并在 4-7 年后(时间点 2)进行亚组重新入组。对时间点 1 样本进行病毒载量(VL)检测,并对可检测到 VL 的样本进行基因分型。主要终点是时间点 2 之前的治疗失败(VL>1000 拷贝/ml)和死亡。采用多变量回归分析来描述耐药性对死亡、失败和失访的影响,同时调整关键变量。

结果

最初的队列(n=480)中,52%(n=251)为女性,中位年龄为 8 岁,中位 CD4%为 31%,79%(n=379)接受齐多夫定/阿巴卡韦+拉米夫定+依非韦伦/奈韦拉平治疗,中位时间为 2 年。其中,31%(n=149)在时间点 1 失败。在 n=128 的时间点 1 可获得基因型,显示 93%(n=119)广泛耐药,影响二线治疗。在 128 名患者中,22 名在时间点 2 失败,17 名死亡,32 名在时间点 2 之前失访。时间点 1 存在>5 种耐药突变与更高的死亡率[相对危险比(RRR)=8.7,置信区间(CI)2.1 至 36.3]和失访相关(RRR=3.2,CI 1.1 至 9.2)。转换为二线治疗与较低的死亡率(RRR<0.05,CI<0.05 至 0.1)和失访相关(RRR=0.1,CI<0.05 至 0.3)。

结论

在肯尼亚首例一线 ART 失败的围生期感染的 CALWH 中,广泛耐药和二线治疗的有限转换与长期失败和死亡相关。这些发现强调了在这一脆弱人群中维持有效、终生 ART 的紧迫性。

相似文献

引用本文的文献

2
Treatment of Advanced HIV in the Modern Era.现代时代晚期HIV的治疗
Drugs. 2025 May 12. doi: 10.1007/s40265-025-02181-1.
6
Combating antimicrobial resistance in malaria, HIV and tuberculosis.抗疟疾、艾滋病毒和结核病中的抗菌药物耐药性
Nat Rev Drug Discov. 2024 Jun;23(6):461-479. doi: 10.1038/s41573-024-00933-4. Epub 2024 May 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验